GAREN G BOHLIN
CIK 1254705 · COO and Assistant Secretary · last filed 2026-05-26
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.98M
Companies
9
Total Filings
49
Lifetime Open-Market Net
-$1.18M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| KPTI | Director | 18,517 | $2.01 | $37.2K | $81.3K | 15 | 2026-05-26 |
| COLL | Director | 71,000 | $26.60 | $1.89M | -$1.26M | 8 | 2026-05-18 |
| TETRAPHASE PHARMACEUTICALS INC (TTPH) Delisted | Director | — | — | — | $0 | 6 | 2019-06-11 |
| ESPR | Director | 6,960 | $3.18 | $22.1K | $0 | 4 | 2019-04-29 |
| PRTO | Director | 1,238 | $28.15 | $34.9K | $0 | 5 | 2018-06-11 |
| ACUSPHERE INC (ACUS) Delisted | Director | 152,944 | — | — | $0 | 5 | 2009-01-06 |
| Targanta Therapeutics Corp. (TARG) Delisted | Director | — | — | — | $0 | 1 | 2008-06-03 |
| Sirtris Pharmaceuticals, Inc. (SIRT) Delisted | COO and Assistant Secretary | 55,000 | — | — | $0 | 2 | 2008-01-22 |
| PRCS | Director | — | $29.75 | — | $0 | 1 | 2007-02-08 |
Recent Filings · Page 4 of 5
49 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2017-05-25 | ESPR | Grant (A) | — | $0 | EDGAR |
| 2016-06-17 | KPTI | Grant (A) | — | $0 | EDGAR |
| 2016-06-14 | PRTO | Grant (A) | — | $0 | EDGAR |
| 2016-06-13 | ESPR | Grant (A) | — | $0 | EDGAR |
| 2016-06-10 | TETRAPHASE PHARMACEUTICALS INC (TTPH) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-06-11 | TETRAPHASE PHARMACEUTICALS INC (TTPH) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-06-03 | PRTO | Grant (A) | — | $0 | EDGAR |
| 2015-05-26 | KPTI | Grant (A) | — | $0 | EDGAR |
| 2014-07-09 | KPTI | Grant (A) | — | $0 | EDGAR |
| 2013-03-27 | TETRAPHASE PHARMACEUTICALS INC (TTPH) Delisted | Grant (A) | — | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.